Lifetime burden of mood swings and activation of brain norepinephrine turnover in patients with treatment-refractory depressive illness

Journal of Affective Disorders

Volumn 74, Issue 2, 2003, Pages 185-189

  Ehnvall, Anna ^a,b   Sjögren, Magnus ^b   Zachrisson, Olof C G ^b   Ågren, Hans ^c  

^a VARBERG HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cerebrospinal fluid; Depression; Life charting, monoamines; Lifetime burden of depression; Treatment refractory affective disorder

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; HOMOVANILLIC ACID; NORADRENALIN;

ADULT; ARTICLE; CATECHOLAMINE METABOLISM; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DATA ANALYSIS; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; LIFESPAN; MALE; MEDICAL RECORD; MOOD; MOOD DISORDER; MULTIPLE REGRESSION; NORADRENALIN BRAIN LEVEL; PATIENT CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0037386585     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(02)00011-3     Document Type: Article

References (22)

1. Ågren H., Mefford I.N., Rudorfer M.V., Linnoila M., Potter W.Z. Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF. J. Psychiatric Res. 20:1986;175-193.
2. Åsberg M., Bertilsson L., Mårtensson B., Scalia-Tomba G.-P., Thorén P., Träskman-Bendz L. CSF monoamine metabolites in melancholia. Acta Psychiatr. Scand. 69:1984;201-219.
3. Aston-Jones G., Valentino R., Bockstaele E.V., Meyerson A. Locus coeruleus, stress, and PTSD: Neurobiological and clinical parallels. Murburg M. Catecholamine Function in Posttraumatic Stress Disorder: Emerging Concepts. 1994;17-62 American Psychiatric Press, Inc, Washington, DC.
4. Banki C., Bissette G., Arato M., O'Connor L., Nemeroff C. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am. J. Psychiatry. 144:1987;873-877.
5. Blennow K., Wallin A., Gottfries C.-G., Lekman A., Karlsson I., Svennerholm L. Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease. Neurobiol. Aging. 13:1991;107-113.
6. Cullinan W., Herman J., Helmreich D., Watson S. A neuroanatomy of stress. Friedman M., Charney D., Deutch A. Neurobiological and Clinical Consequences of Stress. 1995;3-26 Lippincott-Raven Publishers, Philadelphia.
7. DeBellis M., Baum A., Birmaher B., Keshavan M., Eccard C., Boring A., Jenkins F., Ryan N. Developmental traumatology. Part I: Biological stress systems. Biol. Psychiatry. 45:1999;1259-1270.
8. Ehnvall, A., Ågren, H., 2002. Patterns of sensitisation in the course of affective illness: a life-charting study of treatment-refractory depressed patients. J. Affect. Disord., in press.
9. Geracioti T.D. Jr., Loosen P., Ekhator N., Schmidt D., Chambliss B., Baker D., Kasckow J., Richtand N., Keck P., Ebert M. Uncoupling of serotonergic and noradrenergic systems in depression: preliminary evidence from continuous cerebrospinal fluid sampling. Depression Anxiety. 6:1997;89-94.
10. Hsiao J.K., Potter W.Z., Ågren H., Owen R.R., Pickar D. Clinical investigation of monoamine neurotransmitter interactions. Psychopharmacology. 112:1993;76-84.
11. Holsboer F., Liebl R., Hofschuster E. Repeated dexamethasone suppression test during depressive illness: normalizing of test results compared with clinical improvement. J. Affect. Disord. 4:1982;93-101.
12. Koslow S., Maas J., Bowden C., Davis J., Hanin I., Javaid J. CSF and urinary biogenic amines and metabolites in depression and mania. Arch. Gen. Psychiatry. 40:1983;999-1010.
13. McEwen B. Stressful experience, brain, and emotions: developmental, genetic, and hormonal influences. Gazzaniga M. The Cognitive Neurosciences. 1995;1117-1135 The MIT press, Cambridge, MA.
14. McEwen B., Stellar E. Stress and the individual: Mechanisms leading to disease. Arch. Int. Med. 153:1993;2093-2101.
15. Nemeroff C. The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Molecular Psychiatry. 1:1996;336-342.
16. Nemeroff C., Widerlöv E., Bissette G. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science. 226:1984;1342-1344.
17. Parnetti L., Gottfries J., Karlsson I. Monoamines and their metabolites in cerebrospinal fluid of patients with senile dementia of Alzheimer type using high performance liquid chromatography and gas chromatography-mass spectometry. Acta Psychiatr. Scand. 75:1987;542-548.
18. Schmider J., Lammers C., Gotthardt V., Dettling M., Holsboer F., Heuser I. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression and in normal controls: 1. Biol. Psychiatry. 38:1995;797-802.
19. Vestergaard P., Sørensen T., Hoppe E., Rafaelsen O., Yates C., Nicolaou N. Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders. Acta Psychiatr. Scand. 58:1978;88-96.
20. Yehuda R., Giller E., Levengood R., Southwick S., Siever L. Hypothalamic-pituary-adrenal functioning in post-traumatic stress disorder: expanding the concept of the stress response spectrum. Friedman M., Charney D., Deutch A. Neurobiological and Clinical Consequences of Stress: From Normal Adaptation to Post-Traumatic Stress Disorder. 1995;351-365 Lippincott-Raven Publishers, Philadelphia.
21. Yehuda R., Giller E., Southwick S., Kahana B., Boisenau D., Xiaowan M., Mason J. Relationship between catecholamine excretion and PTSD symptoms in Vietnam combat Veterans and Holocaust survivors. Murburg M. Catacholamine Function in Post-traumatic Stress Disorder. 1994;203-219 American Psychiatric Press, Inc, Washington, DC.
22. Yehuda R., Southwick S., Giller E., Xiaowan M., Mason J. Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. J. Mental Nervous Dis. 180:1992;321-325.